Case mock-ups bring QbD to life

Mock implementations of quality by design processes, based on actual projects underway, may help bridge the gap between big pharma companies that have the resources to participate in its development and smaller players waiting for signs that QbD will work for them. The implementations were presented at a meeting hosted by the Parenteral Drug Association and EFPIA, the European drug industry association. Article

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.